9:35am ET
Health and Healthcare
8 Major Biopharma Events Coming Later in 2016 and in 2017
FDA rulings can make or break some companies. 24/7 Wall St. has collected eight key FDA decisions coming up in 2016 or 2017.
Companies
/Healthcare
Incyte Corp
$124.37
▼ $3.37 (−2.64%) today
Markets closed · 5:54am ET
INCY Coverage
Page 68:55am ET
Investing
Top Analyst Upgrades and Downgrades: Schwab, Dean Foods, HollyFrontier, Incyte, Newfield Exploration, Nike and More
The top analyst upgrades, downgrades and initiations seen on Wednesday, March 23, include Charles Schwab, Dean Foods, HollyFrontier, Incyte, Newfield Exploration and Nike.
10:10am ET
Investing
Massive Biotech Purchases Highlight Insider Buying: Incyte, TransDigm, Prospect Capital, Xenoport and More
Despite the market rally, insiders are still buying at big levels, while insider selling remains dormant. This is a very positive sign for equity investors and the market as a whole.
10:15am ET
Health and Healthcare
4 BioPharma Movers That Cannot Be Ignored
These biotech companies 24/7 Wall St. has picked stood out from the rest with big moves over the course of last week.
9:15am ET
Health and Healthcare
Incyte Underwhelms With Earnings
Incyte reported better-than-expectged fourth-quarter financial results after the markets closed on Wednesday.
Chris Lange 10:10am ET
Health and Healthcare
Despite Target Cuts, Analysts Stick With Incyte for Big Upside
After the announcement that its Phase 2 trial of Ruxolitinib would be stopped a few analysts took a deeper look at Incyte and realized that it might not be as bad as…
Chris Lange 8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Boeing, eBay, Facebook, Incyte, Kinder Morgan, PayPal, Qualcomm, US Steel and More
Thursday's top analyst calls include Boeing, eBay, Facebook, Incyte, Kinder Morgan, PayPal, Qualcomm and U.S. Steel.
11:45am ET
Health and Healthcare
Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs
Credit Suisse sees solid fundamentals, despite a harsh market landscape, for large-cap biotech firms. It initiated several top biotech stocks with an Outperform rating.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: AMD, Amazon, Celgene, Comerica, Fortinet, Gilead, Lennar, Netflix, Voya, Wayfair and Many More
Wednesday's top analyst calls include AMD, Amazon.com, Celgene, Comerica, Fortinet, Gilead Sciences, Lennar, Netflix, Voya and Wayfair.
8:40am ET
Investing
Top Analyst Upgrades and Downgrades: Bluebird Bio, Check Point, Comcast, Eli Lilly, Hyatt, Lockheed Martin, Rite Aid and Many More
The top analyst calls for Wednesday, January 6, 2016, include Bluebird Bio, Check Point Software, Comcast, Eli Lilly, Hyatt Hotels, Lockheed Martin and Rite Aid.
8:40am ET
Investing
Hot Biotech Stocks Highlight Jefferies Top Growth Stocks to Buy This Week
This week the Jefferies analysts are positive on companies that took a shot price-wise last week and may be offering an even better entry point for investors.
9:25am ET
Health and Healthcare
Big Biotech Is Cheap With Strong Cash Flows: 3 to Buy Before Earnings
These three top biotech names are very good bets for investors looking to add high-quality companies with less volatility and binary clinical data risk.
8:40am ET
Health and Healthcare
Why Merrill Lynch Now Favors Large Cap Leaders in Biotech
These four top large cap biotechs are very good bets for investors looking to add high-quality companies with less volatility and binary clinical data risk.
8:20am ET
Health and Healthcare
Jefferies Starts Coverage on Biotechs: 3 Top Stocks to Buy Now
In a new and very comprehensive report, Jefferies starts coverage on biotechs with some very targeted stock selections.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Exxon, Home Depot, Lululemon, 3M, Vodafone, Mondelez, Chevron and More
Monday's top analyst upgrades, downgrades and initiations include Exxon Mobil, Home Depot, Lululemon Athletica, 3M, Vodafone, Mondelez International and Chevron.